Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical ...( Patrick Kenny Former Senior Clin...),Health

Patrick Kenny, Former Senior Clinical Research Associate at Kendle

International, Inc., Joins Catalyst

CORAL GABLES, Fla., March 5 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) today announced the appointment of Patrick Kenny as Director - Corporate Clinical Compliance. In this capacity, Mr. Kenny will be responsible for ensuring the effectiveness and GCP compliance of the CROs, clinical contractors and clinical trial sites involved in the clinical trials conducted under Catalyst's sponsorship.

Commenting on today's announcement, Douglas Winship, Catalyst's Vice President of Regulatory Operations, noted, "Mr. Kenney joins Catalyst at a key point of our corporate development, the initiation of our first series of U.S. clinical trials. He will play a critical role in auditing the performances of our contractors involved in our sponsored clinical trials to assure overall compliance with current Good Clinical Practices guidelines. Pat will also identify opportunities for implementation of improvement programs and training needs, as well as help determine additional resource needs required by the clinical trial sites to facilitate expeditious trial completion. I am confident that his strength in the areas of clinical development planning and coordination, FDA regulations and project leadership will allow him to play an important role at Catalyst as we push forward with the clinical development and ultimate commercialization of CPP-109 for the treatment of both cocaine addiction and methamphetamine addiction."

Mr. Kenny brings to Catalyst 18 years of experience in conducting clinical research programs leading to product approvals in the pharmaceutical industry. Prior
'/>"/>